Elicio Therapeutics, Inc. (ELTX) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $24.23M | -38.7% |
| 2024 | $39.49M | +150.4% |
| 2023 | $15.77M | +14.7% |
| 2022 | $13.75M | -8.4% |
| 2021 | $15.01M | -89.1% |
| 2020 | $137.80M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $24.23M | -38.7% |
| 2024 | $39.49M | +150.4% |
| 2023 | $15.77M | +14.7% |
| 2022 | $13.75M | -8.4% |
| 2021 | $15.01M | -89.1% |
| 2020 | $137.80M | — |